• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠和人类载脂蛋白C对灌注大鼠肝脏摄取富含甘油三酯的脂蛋白及其残粒的抑制作用。

Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.

作者信息

Windler E, Havel R J

出版信息

J Lipid Res. 1985 May;26(5):556-65.

PMID:4020294
Abstract

Like rat C apolipoproteins, each of the C apolipoproteins from human blood plasma (C-I, C-II, C-III-1, and C-III-2) bound to small chylomicrons from mesenteric lymph of estradiol-treated rats and inhibited their uptake by the isolated perfused rat liver. This inhibitory effect of the C apolipoproteins was independent of apolipoprotein E, which is present only in trace amounts in these chylomicrons. Addition of rat apolipoprotein E to small chylomicrons from mesenteric lymph of normal rats did not displace C apolipoproteins and had no effect on the uptake of these particles by the perfused liver, indicating that an increased ratio of E apolipoproteins to C apolipoproteins on chylomicron particles, unaccompanied by depletion of the latter, may not promote recognition by the chylomicron remnant receptor. The hepatic uptake of remnants of rat hepatic very low density lipoproteins (VLDL) and small chylomicrons, which had been produced in functionally eviscerated rats, was also inhibited by addition of C apolipoproteins. These observations are consistent with the hypothesis that the addition of all of the C apolipoproteins to newly secreted chylomicrons and VLDL inhibits premature uptake of these particles by the liver and that depletion of all of these apolipoproteins from remnant particles facilitates their hepatic uptake. Remnants of chylomicrons and VLDL incubated with rat C apolipoproteins efficiently took up C-III apolipoproteins, but not apolipoprotein C-II (the activator protein for lipoprotein lipase). Preferential loss of apolipoprotein C-II during remnant formation may regulate the termination of triglyceride hydrolysis prior to complete removal of triglycerides from chylomicrons and VLDL.

摘要

与人血浆中的载脂蛋白C(C-Ⅰ、C-Ⅱ、C-Ⅲ-1和C-Ⅲ-2)一样,来自雌二醇处理大鼠肠系膜淋巴的载脂蛋白C与小乳糜微粒结合,并抑制其被分离的灌注大鼠肝脏摄取。载脂蛋白C的这种抑制作用与载脂蛋白E无关,后者在这些乳糜微粒中仅微量存在。向正常大鼠肠系膜淋巴的小乳糜微粒中添加大鼠载脂蛋白E不会取代载脂蛋白C,对灌注肝脏摄取这些颗粒也没有影响,这表明乳糜微粒颗粒上E载脂蛋白与C载脂蛋白的比例增加,而后者没有减少,可能不会促进乳糜微粒残粒受体的识别。添加载脂蛋白C也会抑制功能性去内脏大鼠产生的大鼠肝极低密度脂蛋白(VLDL)残粒和小乳糜微粒的肝脏摄取。这些观察结果与以下假设一致:向新分泌的乳糜微粒和VLDL中添加所有载脂蛋白C会抑制肝脏对这些颗粒的过早摄取,而残粒颗粒中所有这些载脂蛋白的减少则有助于它们被肝脏摄取。与大鼠载脂蛋白C一起孵育的乳糜微粒和VLDL残粒有效地摄取了载脂蛋白C-Ⅲ,但没有摄取载脂蛋白C-Ⅱ(脂蛋白脂肪酶的激活蛋白)。在残粒形成过程中载脂蛋白C-Ⅱ的优先丢失可能在从乳糜微粒和VLDL中完全去除甘油三酯之前调节甘油三酯水解的终止。

相似文献

1
Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.大鼠和人类载脂蛋白C对灌注大鼠肝脏摄取富含甘油三酯的脂蛋白及其残粒的抑制作用。
J Lipid Res. 1985 May;26(5):556-65.
2
The uptake of chylomicron remnants and very low density lipoprotein remnants by the perfused rat liver.
J Biol Chem. 1984 Aug 10;259(15):9662-6.
3
Comparison of binding and removal of remnants of triglyceride-rich lipoproteins of intestinal and hepatic origin by rat liver in vitro.大鼠肝脏体外对肠道和肝脏来源的富含甘油三酯脂蛋白残余物的结合与清除比较。
Am J Physiol. 1982 Nov;243(5):G389-95. doi: 10.1152/ajpgi.1982.243.5.G389.
4
Role of high density lipoproteins in regulation of hepatic fatty acid synthesis by chylomicron and very low density lipoprotein remnants.高密度脂蛋白在乳糜微粒和极低密度脂蛋白残粒对肝脏脂肪酸合成的调节中的作用。
J Biol Chem. 1983 Apr 25;258(8):4746-9.
5
Determinants of hepatic uptake of triglyceride-rich lipoproteins and their remnants in the rat.大鼠肝脏对富含甘油三酯的脂蛋白及其残粒摄取的决定因素。
J Biol Chem. 1980 Jun 10;255(11):5475-80.
6
Regulation of the hepatic uptake of triglyceride-rich lipoproteins in the rat. Opposing effects of homologous apolipoprotein E and individual C apoproteins.大鼠肝脏对富含甘油三酯脂蛋白摄取的调节。同源载脂蛋白E和单个C载脂蛋白的相反作用。
J Biol Chem. 1980 Sep 10;255(17):8303-7.
7
Binding of rat chylomicrons and their remnants to the hepatic low-density-lipoprotein receptor and its role in remnant removal.大鼠乳糜微粒及其残粒与肝脏低密度脂蛋白受体的结合及其在残粒清除中的作用。
Biochem J. 1988 Jun 1;252(2):553-61. doi: 10.1042/bj2520553.
8
Differences in apolipoprotein and lipid composition between human chylomicron remnants and very low density lipoproteins isolated from fasting and postprandial plasma.从空腹和餐后血浆中分离出的人乳糜微粒残粒与极低密度脂蛋白之间载脂蛋白和脂质组成的差异。
J Lipid Res. 1998 Jul;39(7):1412-20.
9
Apolipoprotein C-II deficiency. The role of apolipoprotein C-II in the hydrolysis of triacylglycerol-rich lipoproteins.载脂蛋白C-II缺乏症。载脂蛋白C-II在富含三酰甘油脂蛋白水解中的作用。
Biochim Biophys Acta. 1984 Mar 27;793(1):49-60. doi: 10.1016/0005-2760(84)90052-3.
10
Uptake and degradation of human very-low-density lipoproteins by rat liver endothelial cells in culture.
Biochim Biophys Acta. 1985 May 17;834(3):308-15. doi: 10.1016/0005-2760(85)90003-7.

引用本文的文献

1
Insulin Regulation of Hepatic Lipid Homeostasis.胰岛素对肝脏脂质稳态的调节作用。
Compr Physiol. 2023 Jun 26;13(3):4785-4809. doi: 10.1002/cphy.c220015.
2
Apo CIII Proteoforms, Plasma Lipids, and Cardiovascular Risk in MESA.载脂蛋白 CIII 蛋白亚型、血浆脂质与 MESA 心血管风险
Arterioscler Thromb Vasc Biol. 2023 Aug;43(8):1560-1571. doi: 10.1161/ATVBAHA.123.319035. Epub 2023 Jun 15.
3
Broadening the Scope of Dyslipidemia Therapy by Targeting APOC3 (Apolipoprotein C3) and ANGPTL3 (Angiopoietin-Like Protein 3).通过靶向 APOC3(载脂蛋白 C3)和 ANGPTL3(血管生成素样蛋白 3)拓宽血脂异常治疗范围。
Arterioscler Thromb Vasc Biol. 2023 Mar;43(3):388-398. doi: 10.1161/ATVBAHA.122.317966. Epub 2022 Dec 29.
4
Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review.载脂蛋白 C1 在脂蛋白代谢、动脉粥样硬化和糖尿病中的作用:系统评价。
Cardiovasc Diabetol. 2022 Dec 5;21(1):272. doi: 10.1186/s12933-022-01703-5.
5
Lipoprotein sialylation in atherosclerosis: Lessons from mice.载脂蛋白唾液酸化在动脉粥样硬化中的作用:来自小鼠的启示。
Front Endocrinol (Lausanne). 2022 Sep 6;13:953165. doi: 10.3389/fendo.2022.953165. eCollection 2022.
6
Elevated Levels of Apolipoprotein CIII Increase the Risk of Postprandial Hypertriglyceridemia.载脂蛋白 CIII 水平升高增加餐后高甘油三酯血症的风险。
Front Endocrinol (Lausanne). 2021 Apr 23;12:646185. doi: 10.3389/fendo.2021.646185. eCollection 2021.
7
Apolipoprotein CIII Deficiency Protects Against Atherosclerosis in Knockout Rabbits.载脂蛋白 CIII 缺乏可预防敲除兔动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2020 Sep;40(9):2095-2107. doi: 10.1161/ATVBAHA.120.314368. Epub 2020 Aug 6.
8
Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study.载脂蛋白 CIII 可预测冠心病患者的心血管事件:一项前瞻性观察研究。
Lipids Health Dis. 2020 May 30;19(1):116. doi: 10.1186/s12944-020-01293-9.
9
Role of the Gut in Diabetic Dyslipidemia.肠道在糖尿病血脂异常中的作用。
Front Endocrinol (Lausanne). 2020 Mar 13;11:116. doi: 10.3389/fendo.2020.00116. eCollection 2020.
10
Gain and loss events in the evolution of the apolipoprotein family in vertebrata.脊椎动物载脂蛋白家族进化中的获得和丧失事件。
BMC Evol Biol. 2019 Nov 13;19(1):209. doi: 10.1186/s12862-019-1519-8.